PMA supplement

P930038 S093: Angio Seal Vascular Closure Devices

FDA PMA supplement · 30-Day Notice · Terumo Medical Corporation

Key facts

Original PMA P930038
Supplement number S093
Supplement type 30-Day Notice
Reason for the supplement Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name Angio Seal Vascular Closure Devices
Generic name Device, hemostasis, vascular
Applicant Terumo Medical Corporation
Product code MGB
Received date Feb 28, 2019
Decision date Mar 29, 2019

At a glance

  • No Expedited review granted
  • No Approval order on file
  • No Summary of safety and effectiveness on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA supplements

A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA supplements